Respiratory distress syndrome · preterm prelabour rupture of membranes (PPROM)
It is very uncertain whether SOF Immunological sealant changes respiratory distress syndrome (as defined in individual trials) compared with standard care (very low certainty).
1 finding from 1 review
Postpartum endometritis/other sepsis · preterm prelabour rupture of membranes (PPROM)
1 finding from 1 review
Neonatal death (death within the first 28 days of life) · preterm prelabour rupture of membranes (PPROM)
1 finding from 1 review
Neonatal sepsis · preterm prelabour rupture of membranes (PPROM)
It is very uncertain whether SOF Cervical adapter changes neonatal sepsis compared with standard care (very low certainty).
1 finding from 1 review
Respiratory distress syndrome · preterm prelabour rupture of membranes (PPROM)
1 finding from 1 review
Chorioamnionitis · preterm prelabour rupture of membranes (PPROM)
It is very uncertain whether SOF Cervical adapter changes chorioamnionitis (as defined in individual trials) compared with standard care (very low certainty).
1 finding from 1 review
Postpartum endometritis/other sepsis · preterm prelabour rupture of membranes (PPROM)
1 finding from 1 review
Perinatal mortality · preterm prelabour rupture of membranes (PPROM)
1 finding from 1 review
Neonatal death (death within the first 28 days of life) · preterm prelabour rupture of membranes (PPROM)
It is very uncertain whether SOF Immunological sealant changes neonatal death (death within the first 28 days of life) compared with standard care (very low certainty).
1 finding from 1 review
Maternal death · patients with sickle cell disease in pregnancy
1 finding from 1 review
Severe maternal morbidity (pulmonary embolism) · patients with sickle cell disease in pregnancy
1 finding from 1 review
Severe maternal morbidity (congestive cardiac failure) · patients with sickle cell disease in pregnancy
It is very uncertain whether prophylactic changes severe maternal morbidity (congestive cardiac failure) compared with selective blood transfusion (very low certainty).
1 finding from 1 review
Perinatal mortality · patients with sickle cell disease in pregnancy
It is very uncertain whether prophylactic changes perinatal death compared with selective blood transfusion (very low certainty).
1 finding from 1 review
Sickle cell crisis (pain crisis) · patients with sickle cell disease in pregnancy
Prophylactic may leads to lower sickle cell crisis (pain crisis) compared with selective blood transfusion (low certainty).
1 finding from 1 review
Sickle cell crises (acute splenic sequestration) · patients with sickle cell disease in pregnancy
Prophylactic showed no clear difference in sickle cell crises (acute splenic sequestration) compared with selective blood transfusion (low certainty).
1 finding from 1 review
Blood transfusion reaction · patients with sickle cell disease in pregnancy
It is very uncertain whether prophylactic changes blood transfusion reaction compared with selective blood transfusion (very low certainty).
1 finding from 1 review
Severe postpartum haemorrhage · pregnant women giving birth in non‐facility settings
It is very uncertain whether prophylactic oxytocin injection (delivered by community health… changes severe postpartum haemorrhage (> 1000 mL) [ compared with control (no injection) (very low certainty).
1 finding from 1 review
Severe maternal morbidity · pregnant women giving birth in non‐facility settings
1 finding from 1 review
Maternal death · pregnant women giving birth in non‐facility settings
1 finding from 1 review
Postpartum haemorrhage · pregnant women giving birth in non‐facility settings
Prophylactic oxytocin injection (delivered by community health… may leads to lower postpartum haemorrhage (PPH greater or equal to 500 mL) [ compared with control (no injection) (low certainty).
2 findings from 1 review